m-RESIST, a Mobile Therapeutic Intervention for Treatment-Resistant Schizophrenia: Feasibility, Acceptability, and Usability Study

BACKGROUND: In the European Union, around 5 million people are affected by psychotic disorders, and approximately 30%-50% of people with schizophrenia have treatment-resistant schizophrenia (TRS). Mobile health (mHealth) interventions may be effective in preventing relapses, increasing treatment adh...

Descripción completa

Detalles Bibliográficos
Autores principales: Grasa, Eva, Seppälä, Jussi, Alonso-Solis, Anna, Haapea, Marianne, Isohanni, Matti, Miettunen, Jouko, Caro Mendivelso, Johanna, Almazan, Cari, Rubinstein, Katya, Caspi, Asaf, Unoka, Zsolt, Farkas, Kinga, Usall, Judith, Ochoa, Susana, van der Graaf, Shenja, Jewell, Charlotte, Triantafillou, Anna, Stevens, Matthias, Reixach, Elisenda, Berdun, Jesus, Corripio, Iluminada
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2023
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10365616/
https://www.ncbi.nlm.nih.gov/pubmed/37389933
http://dx.doi.org/10.2196/46179

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10365616/
https://www.ncbi.nlm.nih.gov/pubmed/37389933
http://dx.doi.org/10.2196/46179

Ejemplares similares